| Question 27 | |
| Question 9 |
| Question 30 |
| Question 18.3 | Toxic alcohols - features of methanol toxicity |
| Question 15.2 | Tricyclic antidepressant overdose - an ECG exercise |
| Question 13 | |
| Question 11 | Sympathomimetic toxicity - methamphetamine |
| Question 7 | Toxins and their antidotes: digoxin, TCAs, beta blockers and lignocaine |
| Question 1 | Snake bite envenomation - a brown snake, probably Pseudonaja textilis |
| Question 29 | |
| Question 2 | Toxic antiarrhythmic polypharmacy: calcium channel blocker and beta blocker overdose |
| Question 8 | Salicylate toxicity in unusual detail |
| Question 28 | Assessment of poisoning in pregnancy, in childhood, and in old age with renal impairment |
| Question 17 | Salicylate overdose, with a characteristic blood gas |
| Question 26 | |
| Question 21.3 | Toxic alcohols: mechanisms and management of methanol toxicity |
| Question 13.1 | The characteristic biochemistry of propofol infusion syndrome |
| Question 10.1 |
| Question 9 | Paracetamol toxicity, management of acute liver failure, and criteria for transplantation. |
| Question 18.1 | Organophosphate poisoning: clinical features, antidotes, cholinesterase mixing studies. |
| Question 8 | Iron poisoning - clinical features and a detailed discussion of management |
| Question 17 | The pharmacology of phenytoin, in ridiculous detail. |
| Question 4 | Digoxin toxicity (in some considerable detail). |
| Question 15.4 | Activated charcoal-induced bowel obstruction (CT image) |
| Question 10 | Salicylate overdose, with a characteristic blood gas |
| Question 29 |
| Question 5 | Pharmacokinetic changes in critical illness: absorption and clearance |
| Question 29 | Use of activated charcoal in toxicology; role of dialysis and haemoperfusion |
| Question 20 | Propofol infusion syndrome. Risk factors, laboratory evidence, management. |
| Question 28.2 | Tricyclic antidepressant overdose: role of sodium bicarbonate |
| Question 28.1 | |
| Question 22 | Outline the role of vasopressin and its analogues in the critically ill patient.> |
| Question 18 | Iron poisoning - clinical signs, investigations, characteristic ABG findings |
| Question 20 | Ideal body weight, and the influence of morbid obesity on pharmacokinetics. |
| Question 19.1 |
| Question 13 |
| Question 17 | Propofol vs. dexmedetomidine: Comparative pharmacology of sedatives and analgesics |
| Question 14.2 | |
| Question 14.1 |
| Question 2 |
| Question 14 | Calcium channel blocker overdose ... compared with a beta-blocker overdose. |
| Question 3 | Antibiotic pharmacology: ceftriaxone, gentamicin and meropenem. |
| Question 12 | Pharmacology of antiarrhythmic drugs: compare lignocaine, amiodarone and magnesium sulfate. |
| Question 2 |
| Question 18 | |
| Question 16 | Adverse drug reactions |
| Question 11 | Comparative pharmacology of sedatives and analgesics: ketamine vs. morphine vs. dexmedetomidine. |
| Question 1d | Supportive management of the overdose: part of the "Toxicological Primary Survey" |
| Question 1c | |
| Question 1b | Decontamination following overdose: charcoal, PEG, lavage, etc... |
| Question 1a | Immediate management of the undifferentiated overdose: the "Toxicological Primary Survey" |
| Question 9 | Comparative pharmacology of inotropes and vasopressors - dobutamine vs levosimendan |
| Question 10 | Malignant hyperthermia - diagnostic features, complications and treatment |
| Question 9 | Antibiotic pharmacology: ceftriaxone, gentamicin and meropenem. |
| Question 7 |
| Question 7 | Comparative pharmacology of sedatives and analgesics used to control raised intracranial pressure. |
| Question 9 | Pharmacology of antiarrhythmic drugs: compare lignocaine, amiodarone and magnesium sulfate. |
| Question 5 |
| Question 7 | Drug withdrawal states: classical syndromes and their management |
| Question 3 | Comparative pharmacology of sedatives and analgesics : tramadol, celecoxib and ketamine |
| Question 8 |
| Question 6 | Corrosive ingestion: what might be the possible complications |